Temsavir

DB14675InvestigationalSmall molecule

Temsavir: Overview.

Mechanism: Pharmacologically active on Envelope glycoprotein gp160
Curator reviewed
Formula / weight: C₂₄H₂₃N₇O₄ · 473.493 g/mol (avg)
Code names: BMS-626529

Resolves to

Compound

Clinical / RWD

Structure

InChIKeyQRPZBKAMSFHVRW-UHFFFAOYSA-NSMILESCOC1=CN=C(N2C=NC(C)=N2)C2=C1C(=CN2)C(=O)C(=O)N1CCN(CC1)C(=O)C1=CC=CC=C1

Targets

Transporters

What you can answer from here — as of July 07, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

2TransportersSubstrate / inhibitor direction, not just membership

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

10+ReferencesStructured and connected to the statements they support

Which drugs share a target with Temsavir, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.